Inactive Instrument
Lipidor AB Stock Deutsche Boerse AG
Stocks
L7R
SE0012558617
Pharmaceuticals
OTC Markets Traded| 1 day | -50.34% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Chairman | 46 | 2019-12-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -50.34% | -59.44% | - | - | 92.63K | |
| +0.04% | +3.34% | +51.12% | +101.82% | 1,027B | |
| -0.09% | +1.66% | +55.02% | +66.18% | 651B | |
| -0.02% | +2.66% | +18.91% | +71.47% | 467B | |
| -1.22% | +3.66% | +36.44% | +38.32% | 350B | |
| -0.79% | +2.73% | +19.03% | +25.08% | 268B | |
| +0.58% | +6.76% | +11.13% | +16.52% | 257B | |
| +1.55% | +2.20% | +39.81% | +46.55% | 205B | |
| +0.79% | +1.84% | -28.27% | -56.71% | 190B | |
| -0.52% | +4.45% | +32.12% | +98.51% | 187B | |
| Average | -4.85% | +2.96% | +26.15% | +45.30% | 400.23B | |
| Weighted average by Cap. | +0.23% | +3.01% | +35.17% | +61.81% |
Employees
4
Sector
Pharmaceuticals
